| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Revenue | $1.23B | +2.1% |
| Cost of Revenue | $785.3M | -3.7% |
| Gross Profit | $446.2M | +14.4% |
| R&D Expense | $51.0M | +0.8% |
| SG&A Expense | $287.6M | +6.4% |
| Operating Income | $100.4M | +55.1% |
| Pre-tax Income | $105.8M | +71.0% |
| Income Tax | $24.7M | +488.7% |
| Net Income | $76.1M |
| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $226.5M | +37.6% |
| Accounts Receivable | $42.9M | +1.5% |
| Current Assets | $520.3M | +23.1% |
| Total Assets | $626.2M | +13.8% |
| Current Liabilities | $293.0M | +4.9% |
| Total Liabilities | $295.8M | +4.3% |
| Stockholders' Equity | $305.1M | +23.9% |
| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $127.1M | +62.5% |
| Capital Expenditures | $20.8M | +9.8% |
| Investing Cash Flow | -$20.7M | -2672.6% |
| Financing Cash Flow | -$23.4M | -36.0% |
| Free Cash Flow | $106.3M | +79.3% |
| +18.1% |
| EPS (Basic) | $3.02 | +18.4% |
| EPS (Diluted) | $3.01 | +18.5% |